Delivery Order SPE2DB22D3102-SPE2DB24FL2AT
Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,177.31 Firm Fixed Price Delivery Order has an ultimate completion date of December 16, 2024. The contract provides for the delivery of MENQUADFI VIAL 0.5ML medical supplies, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,903.12 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies. It is an order under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $5,268.60 firm fixed-price contract is for the supply of "MENQUADFI VIAL 0.5ML," a pharmaceutical product. The contract has an ultimate completion date of September 4, 2024. Amerisourcebergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,618.30 firm fixed-price contract is for the delivery of MENQUADFI VIAL 0.5ML medical supplies, with a completion date of November 15, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $22,690.64 award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products. The delivery order has an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $11,437.35 firm-fixed-price contract is for the supply of 4565452753 MENQUADFI VIAL 0.5ML pharmaceutical products. The award has an ultimate completion date of August 15, 2024. Amerisourcebergen is a major pharmaceutical distributor that supports various government agencies and healthcare programs through multiple indefinite delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company and subsidiary of Amerisourcebergen Corporation. The $1,404.96 firm fixed-price delivery order is for the supply of MENQUADFI VIAL 0.5ML medical products. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award for $4,566.12 was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with an ultimate completion date of August 16, 2023. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $9,039.53, is for MENQUADFI VIAL 0.5ML medical supplies. The contract has a period of performance through January 9, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4565220495 MENQUADFI VIAL 0.5ML. The contract is a firm fixed-price delivery order with a ceiling value of $3,512.40 and an ultimate completion date of July 23, 2024. Amerisourcebergen has been awarded multiple indefinite delivery contracts (IDCs) by the DLA and other federal agencies, including a $999,999,999 IDC with the DLA Troop...